A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections.

Launched by HAPPY V · Oct 28, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how a prebiotic and probiotic supplement can help relieve symptoms of bacterial vaginosis and yeast infections in women. Bacterial vaginosis and yeast infections can cause discomfort, including itchiness, unusual discharge, and an unpleasant odor. In this study, women aged 25 and older who have these symptoms and some digestive issues will be divided into three groups. Each group will take two capsules daily for 30 days—one group will take the actual supplement, while the others will receive placebos, which are inactive versions of the product. The goal is to see how this supplement affects their symptoms and overall vaginal health.

To be eligible for the trial, participants must be generally healthy women over the age of 25 who have been experiencing symptoms related to bacterial vaginosis or yeast infections, along with some digestive discomfort. They should not have any serious health conditions, be pregnant or breastfeeding, or have recently started any new medications or supplements for vaginal health. Participants will need to avoid other vaginal health treatments during the study. This trial is not yet recruiting, but it aims to provide valuable insights into improving women's health and comfort.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women
• • Age 25+
• • Self-reported concerns symptoms associated with bacterial vaginosis or candida overgrowth, including itchiness, redness, abnormal discharge, and an unpleasant odor.
• • Suffers from digestive issues, including bloating, gas, or other digestive discomfort.
• • Generally healthy - do not live with any uncontrolled chronic diseases.
• • Willing to avoid using any vaginal health-related medications, supplements, and herbal remedies for the duration of this study.
• • If taking oral supplements or herbal remedies targeted at vaginal health, has been consistently taking these for at least 3 months prior to starting the study and is willing to maintain this routine for the study duration.
• Exclusion Criteria:
• • Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
• • Planning to undergo any procedure related to their vaginal health.
• • Started any new medications or supplements that target vaginal health in the past 3 months.
• • Anyone with known severe allergic reactions that require the use of an Epi-Pen, or any known allergies to any of the product ingredients
• • Women who are pregnant, breastfeeding, or attempting to conceive
• • Unwilling to follow the study protocol
• • Anyone who has undergone any surgeries or invasive treatments in the last three months or has any planned during the study period.